Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switching to bisoprolol + amlodipine single-pill in Chinese hypertensive patients
ChiCTR2300069366Phase 4Not yet recruiting
- Sponsor
- Beijing An Zhen Hospital
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of bisoprolol + amlodipine in essential hypertension, sponsored by Beijing An Zhen Hospital. Primary endpoints: Change in office systolic blood pressure (SBP) and Office blood pressure control rate. Planned start Dec 2021; status: not yet recruiting.
02
Drugs
bisoprolol + amlodipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on ChiCTR2300069366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300069366.